NCT03976843: Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 175 taking part
- Started
- 4 Dec 2019
- Primary completion
- 19 Nov 2027
- Arms
- 1/18F-DCFPyL PET/CT + radical prostatectomy
- Results
- None posted
- 6 Jun 2019: Trial registered
- 4 Dec 2019: Trial started